Literature DB >> 15587814

The roles of different types of serotonin receptors in activation of the hypophyseal-testicular complex induced in mice by the presence of a female.

T G Amstislavskaya1, N K Popova.   

Abstract

Placing of receptive females in the sector of a cage separated by a partition preventing physical contact but allowing sight and olfaction induced increases in blood testosterone levels in male mice. The selective agonist of 5-HT1A receptors 8-OH-DPAT (0.1 mg/kg) and the mixed 5-HT1A/1B receptor agonist eltoprazine (3.0 and 10.0 mg/kg) blocked the activatory effect of presentation of females on the hypothalamohypophyseal-testicular complex (HHTC) in males, while the 5-HT1A receptor antagonist p-MPPI (0.2 mg/kg) prevented the inhibitory effects of 8-OH-DPAT and eltoprazine. The 5-HT1B receptor agonist CGS-12066A (1.0 and 2.0 mg/kg) had no effect, while the mixed 5-HT1B/2C agonist TFMPP (5.0 mg/kg) blocked the increase in blood testosterone in males in response to presentation of females. The 5-HT2A receptor antagonist ketanserin (1.0 and 2.0 mg/kg) prevented the increase in testosterone induced by the presence of females. The 5-HT3 receptor antagonist ondansetron (0.05 and 0.1 mg/kg) increased the initial plasma testosterone level but blocked activation of the HHTC induced by the presence of receptive females. These results led to the conclusion that 5-HT receptors are involved in controlling the sexual activation of males. Different types and even subtypes of the same type of 5-HT receptor had different effects, both inhibitory and activatory, on activation of the HHTC by receptive females. Blockade of HHTC activation induced by the presence of females appears to involve 5-HT1A and 5-HT2C receptors, while activation involves 5-HT2A and 5-HT3 receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15587814     DOI: 10.1023/b:neab.0000038136.27999.3d

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  12 in total

Review 1.  A review of central 5-HT receptors and their function.

Authors:  N M Barnes; T Sharp
Journal:  Neuropharmacology       Date:  1999-08       Impact factor: 5.250

2.  The role of the adrenoceptors in the activation of the hypothalamic-pituitary-testicular complex of mice induced by the presence of a female.

Authors:  E V Naumenko; T G Amstislavskaja; A V Osadchuk
Journal:  Exp Clin Endocrinol       Date:  1991-03

3.  [Sexual motivation in male mice induced by the presence of the female].

Authors:  N K Popova; T G Amstislavskaia; S A Kucheriavyĭ
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  1998 Jan-Feb       Impact factor: 0.437

Review 4.  5-HT2 receptor subtypes: a family re-united?

Authors:  G Baxter; G Kennett; F Blaney; T Blackburn
Journal:  Trends Pharmacol Sci       Date:  1995-03       Impact factor: 14.819

5.  4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.

Authors:  M P Kung; D Frederick; M Mu; Z P Zhuang; H F Kung
Journal:  J Pharmacol Exp Ther       Date:  1995-01       Impact factor: 4.030

6.  [Role of the genotype and zoosocial behavior types in regulating testicular endocrine function in mice].

Authors:  A V Osadchuk; E V Naumenko
Journal:  Dokl Akad Nauk SSSR       Date:  1981

7.  [The activation pathways and changes in the endocrine function of the testes evoked by the effect of the presence of the female].

Authors:  T G Amstislavskaia; A V Osadchuk; E V Naumenko
Journal:  Probl Endokrinol (Mosk)       Date:  1989 Nov-Dec

Review 8.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

9.  Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist.

Authors:  R F Neale; S L Fallon; W C Boyar; J W Wasley; L L Martin; G A Stone; B S Glaeser; C M Sinton; M Williams
Journal:  Eur J Pharmacol       Date:  1987-04-07       Impact factor: 4.432

10.  Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat.

Authors:  S Ahlenius; K Larsson; A Wijkström
Journal:  Eur J Pharmacol       Date:  1991-08-06       Impact factor: 4.432

View more
  3 in total

Review 1.  Neuroanatomical dichotomy of sexual behaviors in rodents: a special emphasis on brain serotonin.

Authors:  Mariana Angoa-Pérez; Donald M Kuhn
Journal:  Behav Pharmacol       Date:  2015-09       Impact factor: 2.293

2.  A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.

Authors:  Enric Alvarez; Victor Perez; Marianne Dragheim; Henrik Loft; Francesc Artigas
Journal:  Int J Neuropsychopharmacol       Date:  2011-07-18       Impact factor: 5.176

Review 3.  Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder.

Authors:  Enric Alvarez; Victor Perez; Francesc Artigas
Journal:  Neuropsychiatr Dis Treat       Date:  2014-07-15       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.